In Vitro and In Vivo Anticancer Activity of Basil (
anticancer
antioxidant activity
apoptosis
basil extract
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 May 2022
11 May 2022
Historique:
received:
11
04
2022
revised:
06
05
2022
accepted:
09
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Cancer is an irregular proliferation of cells that starts with a gene mutation that alters cellular function, is triggered by several factors, and can be inherited or acquired. The aim of this review is to discuss the anticancer activity of basil and its components' strength, focusing on its implication in cancer prevention and treatment. This systematic review involves all of the studies published from 1 January 2010 through 1 January 2022. In this review, 16 research articles are included to discuss the potential anticancer ability of the extracts of various Based on 16 published studies, basil demonstrates important anticancer activities in vivo and vitro models, and it could act as a potential cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Cancer is an irregular proliferation of cells that starts with a gene mutation that alters cellular function, is triggered by several factors, and can be inherited or acquired. The aim of this review is to discuss the anticancer activity of basil and its components' strength, focusing on its implication in cancer prevention and treatment.
METHODS
METHODS
This systematic review involves all of the studies published from 1 January 2010 through 1 January 2022.
RESULTS
RESULTS
In this review, 16 research articles are included to discuss the potential anticancer ability of the extracts of various
CONCLUSIONS
CONCLUSIONS
Based on 16 published studies, basil demonstrates important anticancer activities in vivo and vitro models, and it could act as a potential cancer.
Identifiants
pubmed: 35625980
pii: cancers14102375
doi: 10.3390/cancers14102375
pmc: PMC9139360
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cancers (Basel). 2022 Apr 04;14(7):
pubmed: 35406599
Ultrason Sonochem. 2021 Jan;70:105325
pubmed: 32920300
Biomolecules. 2019 Jul 30;9(8):
pubmed: 31366167
Ann N Y Acad Sci. 2017 Aug;1401(1):19-27
pubmed: 28891091
Food Chem. 2016 Nov 1;210:402-14
pubmed: 27211664
Comb Chem High Throughput Screen. 2016;19(8):656-666
pubmed: 27396915
Genes Nutr. 2019 May 22;14:18
pubmed: 31143299
Antioxidants (Basel). 2020 Apr 29;9(5):
pubmed: 32365570
Biol Res. 2021 Jan 6;54(1):2
pubmed: 33407904
Biomed Pharmacother. 2017 Dec;96:1253-1266
pubmed: 29198745
Nat Prod Res. 2015;29(22):2149-54
pubmed: 25554015
Antibodies (Basel). 2020 Jul 20;9(3):
pubmed: 32698317
Foods. 2022 Apr 26;11(9):
pubmed: 35563962
J Agric Food Chem. 2001 Jan;49(1):517-21
pubmed: 11170620
Biomark Res. 2022 Jan 27;10(1):5
pubmed: 35086565
Sci Rep. 2019 Mar 25;9(1):5078
pubmed: 30911084
Br J Pharmacol. 2017 Jun;174(11):1226-1243
pubmed: 27646173
Cancer Lett. 2013 Aug 19;336(2):270-80
pubmed: 23523869
Cancer Biol Ther. 2013 May;14(5):417-27
pubmed: 23380593
Food Chem. 2015 Apr 1;172:71-7
pubmed: 25442525
Food Chem Toxicol. 2022 Jun;164:113039
pubmed: 35461962
Cell Death Differ. 2011 Sep;18(9):1441-9
pubmed: 21455218
Pharmacognosy Res. 2016 Apr-Jun;8(2):118-22
pubmed: 27034602
Biomed Pharmacother. 2018 Jul;103:381-390
pubmed: 29674273
Biomolecules. 2019 Aug 27;9(9):
pubmed: 31461995
Int J Mol Sci. 2017 Aug 17;18(8):
pubmed: 28817103
Pak J Biol Sci. 2020 Jan;23(8):1010-1017
pubmed: 32700851
Heliyon. 2021 Jul 10;7(7):e07537
pubmed: 34345731
BMC Complement Med Ther. 2020 Sep 14;20(1):278
pubmed: 32928194
Genes Cancer. 2011 Apr;2(4):503-16
pubmed: 21779518
Molecules. 2016 Sep 09;21(9):
pubmed: 27618000
BMC Complement Altern Med. 2019 Dec 4;19(1):349
pubmed: 31801507
Oncol Lett. 2019 Dec;18(6):6563-6571
pubmed: 31819777